(ČIA) AstraZeneca has closed an agreement with the European Commission to supply it with up to 400m doses of the AZD1222 vaccine against COVID-19. The contract, built upon the already existing European Inclusive Vaccine Agreement, will enable EU member states to have equal access to the vaccine without any profit. At the same time, it allows the states to transfer needed doses to other European states.